Pharmaceutical companies help anti-doping officers in their war on doping

Nowadays many pharmaceutical companies are ready to cooperate with anti-doping officials in their war on administration of prohibited medications in sports. It sounds strange but this is the reality. In fact, if you look at the fate of EPO, you can comprehend why drug manufacturers agree to support efforts of anti-doping officials. EPO is actually an effectual remedy for treatment of anemia. A lot of persons with anemia that have used EPO have been treated. But what do you think while hearing about this medicine? Almost any individual associates this remedy only with doping in sports. This product has been abused by the seven-time winner Lance Armstrong that has cheated the whole world. So, EPO is associated just with lying, disgrace, etc. Looking at this situation, pharmaceutical companies try to “defend” their products from the similar fate. That’s why they work together with anti-doping agencies.
However several pharmaceutical companies started to collaborate with anti-doping officers long ago, sometimes there were several problems between them. Anti-doping officers criticized several pharmaceutical companies for their links to doping.
Today relations between anti-doping agencies and drug manufacturers are closer. Pharmaceutical companies share detailed information about new medicines with anti-doping officers. It is precious information for development of detection tests for these medications. While anti-doping officials learn how preparations are manufactured, how they pass into body, how they work in the body, they can develop more efficient tests for these medicines.
For example, the company Roche that introduced the drug CERA helped anti-doping officers to introduce a detection test for it. Later other companies followed the example of Roche. The company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during the 2012 Olympics.
While relations between anti-doping officers and big pharmaceutical companies become closer, smaller drug manufacturers started to cooperate with anti-doping officers too. While previously pharmaceutical companies haven’t wanted to discuss about their relations with anti-doping officials openly, today they don’t fear to announce about this aspect.